The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Theralase Technologies Inc

Venture: TLT
Delayed quote

$0.47

Today's change+0.01 +1.08%
Updated October 20 3:57 PM EDT. Delayed by at least 15 minutes.
 

Theralase Technologies Inc

Venture: TLT
Delayed quote

$0.47

Today's change+0.01 +1.08%
Updated October 20 3:57 PM EDT. Delayed by at least 15 minutes.

Theralase Technologies Inc up $0.01

Theralase Technologies Inc closed up Friday by $0.01 or 1.08% to $0.47. Over the last five days, shares are unchanged, but have gained 84.31% over the last year to date. This security has outperformed the S&P TSX by 10.70% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.05
Updated October 20 3:57 PM EDT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue1110
Total other revenue--------
Total revenue1110
Gross profit0000
Total cost of revenue0000
Total operating expense2222
Selling / general / administrative1111
Research & development1101
Depreciation / amortization--------
Interest expense (income), net operating00--0
Unusual expense (income)--------
Other operating expenses, total--00--
Operating income-2-1-1-1
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-1-1-1
Income after tax-2-1-1-1
Income tax, total--------
Net income-2-1-1-1
Total adjustments to net income--00--
Net income before extra. items-2-1-1-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-1-1-1
Inc. avail. to common incl. extra. items-2-1-1-1
Diluted net income-2-1-1-1
Dilution adjustment0------
Diluted weighted average shares117109115107
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.01-0.01-0.01
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.02-0.01-0.01-0.01